聯環藥業(600513.SH):聯環集團100%股權無償劃轉至揚州市國資委完成工商變更登記手續
格隆匯 12 月 17日丨聯環藥業(600513.SH)公佈,公司於2020年12月16日收到控股股東江蘇聯環藥業集團有限公司(“聯環集團”)有關股權結構調整的通知。
根據《中共揚州市委揚州市人民政府關於市屬國有企業改革重組工作的實施意見》(揚發[2020]49號)文件要求,將江蘇金茂化工醫藥集團有限公司持有的聯環集團100%股權無償劃轉給揚州市人民政府國有資產監督管理委員會(“揚州市國資委”)。該事項已於近日完成工商變更登記手續。
此次控股股東股權結構變更不會導致公司控股股東和實際控制人發生變化,公司控股股東仍為聯環集團,實際控制人仍為揚州市國資委。此次控股股東股權結構變更不會對公司正常生產經營活動等事項產生影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.